Vmn2r80 can impact the functional activity of this protein through various modes of action. Amiloride, for instance, inhibits epithelial sodium channels, which can lead to a reduction in local sodium concentration, potentially altering the receptor's conformation and its ability to bind to its ligands. Similarly, Bupivacaine and Tetrodotoxin are known to block sodium channels, which can reduce the propagation of action potentials in the olfactory system, where Vmn2r80 is expressed. This action indirectly reduces the receptor's signaling capabilities. Oubain targets Na+/K+-ATPase, potentially diminishing the ion gradient essential for the function of ion channels associated with Vmn2r80 signaling pathways, thereby leading to an inhibition of the receptor's function. Conotoxin, which inhibits various calcium channels, can impair neurotransmitter release, consequently affecting the olfactory system and inhibiting the signaling of Vmn2r80. Diltiazem, by blocking L-type calcium channels, can also indirectly inhibit Vmn2r80 function by affecting calcium-dependent processes within the olfactory pathway.
Hexamethonium and Mecamylamine act as nicotinic acetylcholine receptor antagonists, which can inhibit cholinergic activity and indirectly reduce the activity of Vmn2r80, which is involved in pheromone detection. ω-Agatoxin IVA, a P/Q type calcium channel blocker, can inhibit neurotransmitter release in the accessory olfactory bulb, again indirectly influencing Vmn2r80 activity. Capsazepine, a TRPV1 antagonist, can modulate the sensory neuron response, impacting the pathways in which Vmn2r80 is active. Rimonabant, acting as a CB1 cannabinoid receptor antagonist, can alter the modulatory effects of the endocannabinoid system on the olfactory system, which in turn can lead to an inhibition of Vmn2r80. Lastly, SKF-83566, a D1 dopamine receptor antagonist, can disrupt dopamine signaling that plays a regulatory role in the accessory olfactory bulb, where Vmn2r80 is expressed, leading to an inhibition of the receptor's function. Each of these chemicals targets specific pathways or cellular processes that are crucial for the proper functioning of Vmn2r80, thus leading to its inhibition.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride inhibits epithelial sodium channels (ENaC) which could reduce the activity of Vmn2r80 by decreasing the local sodium concentration, thus potentially altering the receptor's conformation and its ability to bind to its ligands. | ||||||
Hexamethonium bromide | 55-97-0 | sc-205712 sc-205712A | 10 g 25 g | $46.00 $64.00 | ||
Hexamethonium is a nicotinic acetylcholine receptor antagonist that could limit the cholinergic activity on the accessory olfactory system, thereby indirectly inhibiting Vmn2r80, which is involved in pheromone detection. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Oubain inhibits Na+/K+-ATPase which could decrease the gradient required for proper function of ion channels associated with the signaling pathways of Vmn2r80, thereby inhibiting its function. | ||||||
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $463.00 | ||
ω-Agatoxin IVA is a P/Q type calcium channel blocker that could indirectly inhibit Vmn2r80 by affecting neurotransmitter release in the accessory olfactory bulb. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Capsazepine is a TRPV1 antagonist that could reduce the activity of Vmn2r80 by modulating the sensory neuron response, which is involved in the pathway where Vmn2r80 is active. | ||||||
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
Rimonabant is a CB1 cannabinoid receptor antagonist that could indirectly inhibit Vmn2r80 by altering the endocannabinoid system's modulatory effects on the olfactory system. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem blocks L-type calcium channels and could indirectly inhibit Vmn2r80 function by affecting calcium-dependent processes in the olfactory pathway where the receptor is active. | ||||||